Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection.
Vigabatrin-induced CNS changes in juvenile rats: Induction, progression and recovery of myelin-related changes.
Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability.
Therapeutic Advances in Pediatric Multiple Sclerosis.
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.
Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment : Case report and review of the literature.
Decoding the substrate supply to human neuronal nitric oxide synthase.
Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data.
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.
Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies.
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.
Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients.
Motor network efficiency and disability in multiple sclerosis.
Neuro-Ophthalmology Annual Review.
The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia.
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis.
Association of interleukin-1 gene cluster polymorphisms and haplotypes with multiple sclerosis in an Iranian population.
[Magnetic resonance imaging of the brain in the monitoring of immune therapy of multiple sclerosis].
Remyelination in multiple sclerosis: realizing a long-standing challenge.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Pages
« first
‹ previous
…
599
600
601
602
603
604
605
606
607
…
next ›
last »